CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax of $539.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax · last filed 2023-11-08
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2023-09-30 was $539.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2023-07-01 was $6.05M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2023-04-01 was -$1.40M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2022-12-31 was -$1.52M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2022 was -$1.52M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2021 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2020 was $0.00.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 12 month |
|---|---|---|---|---|
| 2023-09-30 | $539.00K 10-Q · filed 2023-11-08 | $6.58M derived: sum of 2 quarters · filed 2023-11-08 | $5.18M 10-Q · filed 2023-11-08 | $3.66M derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-07-01 | $6.05M 10-Q · filed 2023-08-09 | $4.64M 10-Q · filed 2023-08-09 | $3.12M derived: sum of 3 quarters · filed 2023-08-09 | $3.12M derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-04-01 | -$1.40M 10-Q · filed 2023-05-11 | -$2.92M derived: sum of 2 quarters · filed 2023-05-11 | -$2.92M derived: sum of 3 quarters · filed 2023-11-08 | -$2.92M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-12-31 | -$1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$1.52M derived: sum of 2 quarters · filed 2023-11-08 | -$1.52M derived: sum of 3 quarters · filed 2023-11-08 | -$1.52M 10-K · filed 2023-02-22 |
| 2022-09-24 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | |
| 2022-06-25 | $0.00 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | ||
| 2022-03-26 | $0.00 10-Q · filed 2023-05-11 | |||
| 2021-12-25 | $0.00 10-K · filed 2023-02-22 | |||
| 2020-12-26 | $0.00 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |